Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme called the Digital Garden, powered by Almirall and strengthens the company's commitment to digital innovation based on developing services and solutions to tackle some of the present and future dermatological challenges. 
Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care program, aiming to create a new paradigm for people with Type 2 diabetes. 
During his keynote at Cerner Health Conference (CHC), the company's Chairman and CEO, Brent Shafer, unveiled a next-generation cognitive health platform, introduced new tools that allow the company's clients to get more from Cerner technology, announced new predictive modeling built directly into the opioid toolkit and opened up free access to the company's training modules. 
Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients' health in the fields of cardiovascular diseases, oncology, ophthalmology, pulmonology, radiology as well as digital therapeutics. 
SilverCloud Health, the world's leading digital mental health company, officially announced its research collaboration with Microsoft to further enhance its online offering with artificial intelligence (AI). SilverCloud Health and Microsoft Labs in Cambridge have been working together over the past 18 months, in research that combines Microsoft's cutting-edge machine learning and 
Highland Marketing, a full service agency for health techmarketing, PR and communications, has appointed Tia Dissanayake to a new account executive role,in which she will support the team withher life science knowledge.
Tia has a strong background in science, having studied biology at university andworked withinthe healthcare and medical sectors.
Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The new lab aims to bolster Novartis AI capabilities from research through commercialization and help accelerate the discovery and development of transformative medicines for patients worldwide.